AU2003217916A8 - Stable formulations of angiotensin converting enzyme (ace) inhibitors - Google Patents

Stable formulations of angiotensin converting enzyme (ace) inhibitors

Info

Publication number
AU2003217916A8
AU2003217916A8 AU2003217916A AU2003217916A AU2003217916A8 AU 2003217916 A8 AU2003217916 A8 AU 2003217916A8 AU 2003217916 A AU2003217916 A AU 2003217916A AU 2003217916 A AU2003217916 A AU 2003217916A AU 2003217916 A8 AU2003217916 A8 AU 2003217916A8
Authority
AU
Australia
Prior art keywords
ace
inhibitors
converting enzyme
angiotensin converting
stable formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003217916A
Other versions
AU2003217916A1 (en
Inventor
Christopher L Pelloni
Robert Gwozdz
Scott Stofik
John C James
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teva Pharmaceuticals USA Inc
Original Assignee
Teva Pharmaceuticals USA Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharmaceuticals USA Inc filed Critical Teva Pharmaceuticals USA Inc
Publication of AU2003217916A1 publication Critical patent/AU2003217916A1/en
Publication of AU2003217916A8 publication Critical patent/AU2003217916A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
AU2003217916A 2002-03-08 2003-03-06 Stable formulations of angiotensin converting enzyme (ace) inhibitors Abandoned AU2003217916A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9384902A 2002-03-08 2002-03-08
US10/093,849 2002-03-08
PCT/US2003/006606 WO2003075842A2 (en) 2002-03-08 2003-03-06 Stable formulations of angiotensin converting enzyme (ace) inhibitors

Publications (2)

Publication Number Publication Date
AU2003217916A1 AU2003217916A1 (en) 2003-09-22
AU2003217916A8 true AU2003217916A8 (en) 2003-09-22

Family

ID=27804229

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003217916A Abandoned AU2003217916A1 (en) 2002-03-08 2003-03-06 Stable formulations of angiotensin converting enzyme (ace) inhibitors

Country Status (2)

Country Link
AU (1) AU2003217916A1 (en)
WO (1) WO2003075842A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2394660A (en) * 2003-12-17 2004-05-05 Niche Generics Ltd Stabilisation of pharmaceutical compositions comprising ACE inhibitor by absence of acidic excipients having large specific surface area, eg silicon dioxide
US20080234353A1 (en) 2004-03-24 2008-09-25 Reynir Eyjolfsson Formulations of Ramipril
EP1729739B1 (en) * 2004-03-29 2016-09-28 Les Laboratoires Servier Process for preparing a solid pharmaceutical composition
SI21800A (en) 2004-05-14 2005-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto New procedure of synthesis of perindopril
PL1948224T3 (en) 2005-11-17 2014-10-31 Silverstone Pharma Est Stable formulation of amorphous perindopril salts, a process for their preparation, especially industrial preparation, and their use in the therapy of hypertension
JP2009538905A (en) * 2006-06-02 2009-11-12 テバ ファーマシューティカル インダストリーズ リミティド Stable formulation comprising moisture sensitive drug and method for producing the same
ES2299157T3 (en) * 2006-06-02 2008-05-16 Teva Pharmaceutical Industries Ltd STABLE FORMULATION THAT UNDERSTANDS A PHARMACO SENSITIVE TO HUMIDITY AND PREPARATION PROCEDURE OF THE SAME.
WO2008000040A1 (en) * 2006-06-30 2008-01-03 Alphapharm Pty Ltd A stabilised composition comprising ace inhibitors
MX2009000358A (en) * 2006-07-10 2009-01-27 Teva Pharma Stable formulation comprising a combination of a moisture sensitive drug and a second drug and manufacturing procedure thereof.
WO2009053994A1 (en) * 2007-10-26 2009-04-30 Matrix Laboratories Limited Process for preparing pure amorphous quinapril hydrochloride
JP6148252B2 (en) 2011-12-21 2017-06-14 ノバルティス ティーアゲズントハイト アーゲー New formulation
US10398705B2 (en) 2012-03-15 2019-09-03 Boehringer Ingelheim Vetmedica Gmbh Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9600120D0 (en) * 1996-01-15 1996-01-15 Astra Ab Novel medical use

Also Published As

Publication number Publication date
AU2003217916A1 (en) 2003-09-22
WO2003075842A2 (en) 2003-09-18
WO2003075842A3 (en) 2004-01-08

Similar Documents

Publication Publication Date Title
AU2003282920A8 (en) Hydantoin derivatives as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme (tace)
HK1077762A1 (en) INHIBITORS OF TFGβ
HK1072545A1 (en) Novel inhibitors of kinases
EP1469873A4 (en) Peptidomimetic inhibitors of post-proline cleaving enzymes
PL377825A1 (en) Diaminotriazoles useful as inhibitors of protein kinases
AU2003220401A8 (en) Uracil derivatives as inhibitors of tnf-alpha converting enzyme (tace) and matrix metalloproteinases
AU2003211093A8 (en) Inhibitors of rgs proteins
AU2003261319A8 (en) Hydantoin derivatives as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme
AU9546501A (en) Pharmaceutical combination of angiotensin ii antagonists and angiotensin i converting enzyme inhibitors
IL165475A0 (en) Nitrooxyderivatives of eyclooxygenase-2 inhibitors
AU2003217916A8 (en) Stable formulations of angiotensin converting enzyme (ace) inhibitors
AU2003300692A1 (en) Stable formulations of ace inhibitors and methods for preparation thereof
AU2003201071A1 (en) Stable pharmaceutical compositions comprising ace inhibitor(s)
AU2003237983A1 (en) Derivatives of azepine and thiazeran as interleukin converting enzyme inhibitors
AU2003290417A8 (en) Process for the preparation of angiotensin converting enzyme (ace) inhibitors and its use
AU2003237981A1 (en) NOVEL INTERLEUKIN-1Beta CONVERTING ENZYME INHIBITORS
EP1352911A4 (en) Angiotensin converting enzyme inhibitors
AU2003249320A8 (en) Novel inhibitors of ubiquitin isopeptidases
AU2003304374A1 (en) Peptide inhibitors of beta-lactamases
AU2003224874A1 (en) INHIBITORS OF SERINE AND METALLO-ss-LACTAMASES
AU2002950185A0 (en) Enzyme inhibitors
AU2003237157A1 (en) Preparation of phosphatase inhibitors
GB0109278D0 (en) Enzyme inhibitors
AU2002308287A1 (en) Pharmaceutical combination of angiotensin ii antagonists and angiotensin i converting enzyme inhibitors
PL366419A1 (en) Pharmaceutical combination of angiotensin ii antagonists and angiotensin i converting enzyme inhibitors

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase